Genus plc (GNS) Given Average Rating of “Hold” by Analysts
Shares of Genus plc (LON:GNS) have earned an average rating of “Hold” from the six analysts that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is GBX 2,217 ($29.64).
A number of research firms have recently commented on GNS. Kepler Capital Markets began coverage on shares of Genus in a research report on Tuesday, November 7th. They issued a “hold” rating and a GBX 2,353 ($31.46) price objective for the company. Peel Hunt restated a “buy” rating and issued a GBX 2,600 ($34.76) price objective on shares of Genus in a research report on Monday, October 9th. Liberum Capital restated a “hold” rating and issued a GBX 2,100 ($28.08) price objective on shares of Genus in a research report on Monday, October 9th. Finally, N+1 Singer upgraded shares of Genus to a “buy” rating and lifted their target price for the company from GBX 1,844 ($24.66) to GBX 2,485 ($33.23) in a research report on Monday, October 30th.
Genus (GNS) traded up GBX 44 ($0.59) during mid-day trading on Monday, hitting GBX 2,480 ($33.16). 84,288 shares of the stock were exchanged, compared to its average volume of 48,289. Genus has a one year low of GBX 1,652 ($22.09) and a one year high of GBX 2,597 ($34.72). The company has a market capitalization of $1,530.00 and a price-to-earnings ratio of 4,679.25.
ILLEGAL ACTIVITY WARNING: This article was reported by Marea Informative and is the property of of Marea Informative. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.mareainformativa.com/2018/01/29/genus-plc-gns-given-average-rating-of-hold-by-analysts-updated-updated-updated.html.
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.